Kedudukan dalam Saham
#32513
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Perubahan (1 hari)
-1.56%
Perubahan (1 tahun)
-7.31%
Perdagangan Pharmena S.a. (PHR)
Harga PHR dengan permodalan pasaran b
Modal pasaran bagi Pharmena S.a.(PHR)
Modal Pasaran: $9.88M
Sehingga August 2026, Pharmena S.a. mempunyai modal pasaran sebanyak $9.88M. Ini menjadikan Pharmena S.a. syarikat ke-32513th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Pharmena S.a. dari 2008 hingga 2026
PHR berbanding dengan 5 teratas yang paling popular stocks
| Harga PHR |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.460T
|
+55,281,968.54%
|
|
|
|
|
$4.489T
|
+45,454,407.56%
|
|
|
|
|
$4.141T
|
+41,921,938.99%
|
|
|
|
|
$3.569T
|
+36,130,097.11%
|
|
|
|
|
$2.798T
|
+28,328,999.74%
|
